Trademark: 79279811
Word
PRESENTIA NIPD GENETICS HEREDITARY CANCER
Status Date
Tuesday, September 29, 2020
Registration Number
6160909
Registration Date
Tuesday, September 29, 2020
Filing Date
Monday, December 23, 2019
Published for Opposition
Tuesday, July 14, 2020
1 Kits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes
44 Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosis, prevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis
42 Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cancer testing, and genetics; scientific research for medical purposes in the field of cancerous diseases
The mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "PRESENTIA" in stylized form, where "PRE" is in yellow, and "SENTIA" is in gray. The third line is "HEREDITARY CANCER" in yellow.
The color(s) yellow and grey is/are claimed as a feature of the mark.
The English translation of "PRESENTIA" in the mark is "TO SENSE".
"NIPD GENETICS" AND "HEREDITARY CANCER"
Jun 14, 2023
Teas Change Of Correspondence Received
Jun 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 2, 2022
Change Of Name/Address Rec'd From Ib
Oct 29, 2022
New Representative At Ib Received
Sep 23, 2022
Teas Change Of Correspondence Received
Sep 23, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 20, 2021
Final Decision Transaction Processed By Ib
Jan 15, 2021
Generic Madrid Transaction Sent To Ib
Jan 15, 2021
Generic Madrid Transaction Created
Dec 29, 2020
Final Disposition Notice Created, To Be Sent To Ib
Sep 29, 2020
Registered-Principal Register
Jul 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2020
Published For Opposition
Jun 24, 2020
Notification Of Notice Of Publication E-Mailed
Jun 9, 2020
Approved For Pub - Principal Register
May 30, 2020
Teas/Email Correspondence Entered
May 29, 2020
Correspondence Received In Law Office
May 29, 2020
Teas Response To Office Action Received
May 26, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 26, 2020
Teas Change Of Correspondence Received
May 26, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 26, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 26, 2020
Teas Change Of Owner Address Received
Apr 24, 2020
Refusal Processed By Ib
Apr 8, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Apr 8, 2020
Refusal Processed By Mpu
Mar 20, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Mar 19, 2020
Non-Final Action Written
Mar 19, 2020
Assigned To Examiner
Mar 6, 2020
Application Filing Receipt Mailed
Mar 2, 2020
New Application Office Supplied Data Entered
Feb 27, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
